Trial FAQs
Note: participants must apply an over-the-counter emollient/moisturizer of their choice for the duration of the study.
Who can participate?
Adults aged 18 and above diagnosed with atopic dermatitis (eczema) may participate.
How long will the study last?
- Approximately 2 years
What are the benefits?
- No cost to participate or receive study treatment
- Regular visits with study doctors who specialize in treating AD (22 study visits)
- Will receive either an investigative drug or a placebo – after week 16 until week 52 all participants receive APG777
What is the inclusion criteria?
- Diagnosis of moderate-to-severe atopic dermatitis (AD) present for at least a year
- AD involvement on 10% or more of your body surface area (BSA)*
- History of inadequate response to treatment with topical medications, or medical determination that topical therapies are inadvisable.
*1% of your body surface area is roughly equal to the palm of your hand (no wrists or fingers)
Clinical Trial for Atopic Dermatitis
Patient Treatment Innovations
Clinical research trials serve as the avenue to allow these treatments and medications to eventually reach the public. Clinical trials involve human volunteer patients, allowing them to receive investigational treatments- a new drug or device. Trials are closely monitored by specialized physicians and are the primary way researchers can evaluate safety, efficacy, benefits and effectiveness of new treatments.
Dr. Yadav is proud to be at the forefront of dermatological research. In partnership with Probity Medical Research, one of the most highly regarded and renowned clinical research organizations across Canada and the United States, Dr. Yadav can offer patients the opportunity to participate in trials that have the newest and most advanced investigational treatments in dermatology.